{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:05:51Z","timestamp":1788260751241,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/hr.2013.134","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T06:42:57Z","timestamp":1380782577000},"page":"246-252","source":"Crossref","is-referenced-by-count":41,"title":["Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease"],"prefix":"10.1038","volume":"37","author":[{"given":"Ryota","family":"Yoshitomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Oniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,3]]},"reference":[{"key":"BFhr2013134_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog CA, Asinger RW, Berger AK, Charytan DM, D\u00edez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E . Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80: 572\u2013586.","journal-title":"Kidney Int"},{"key":"BFhr2013134_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-105-2-173","volume":"105","author":"PN Casale","year":"1986","unstructured":"Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH . Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173\u2013178.","journal-title":"Ann Intern Med"},{"key":"BFhr2013134_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","volume":"114","author":"MJ Koren","year":"1991","unstructured":"Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH . Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345\u2013352.","journal-title":"Ann Intern Med"},{"key":"BFhr2013134_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/0003-4819-110-2-101","volume":"110","author":"D Levy","year":"1989","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Left ventricular mass and incidence of coronary heart disease in an elderly cohort.The Framingham Heart Study. Ann Intern Med 1989; 110: 101\u2013117.","journal-title":"Ann Intern Med"},{"key":"BFhr2013134_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561\u20131566.","journal-title":"N Engl J Med"},{"key":"BFhr2013134_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","volume":"27","author":"A Levin","year":"1996","unstructured":"Levin A, Singer J, Thompson CR, Ross H, Lewis M . Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347\u2013354.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/ndt\/12.4.724","volume":"12","author":"B Tucker","year":"1997","unstructured":"Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR . Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 1997; 12: 724\u2013728.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr2013134_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","volume":"34","author":"A Levin","year":"1999","unstructured":"Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O . Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125\u2013134.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR9","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/01.ASN.0000130566.69170.5E","volume":"15","author":"LP McMahon","year":"2004","unstructured":"McMahon LP, Roger SD, Levin A, Slimheart Investigators Group. Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol 2004; 15: 1640\u20131647.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2013134_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/HJH.0b013e3283424188","volume":"29","author":"G Cioffi","year":"2011","unstructured":"Cioffi G, Tarantini L, Frizzi R, Stefenelli C, Russo TE, Selmi A, Toller C, Furlanello F, de Simone G . Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens 2011; 29: 565\u2013573.","journal-title":"J Hypertens"},{"key":"BFhr2013134_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/hr.2012.40","volume":"35","author":"SC Chen","year":"2012","unstructured":"Chen SC, Chang JM, Liu WC, Chen YY, Chen LI, Huang JC, Yang TK, Su HM, Chen HC . The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res 2012; 35: 832\u2013838.","journal-title":"Hypertens Res"},{"key":"BFhr2013134_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","volume":"46","author":"E Paoletti","year":"2005","unstructured":"Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G . Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46: 320\u2013327.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/HJH.0b013e3283220ecd","volume":"27","author":"E Nardi","year":"2009","unstructured":"Nardi E, Palermo A, Mul\u00e8 G, Cusimano P, Cottone S, Cerasola G . Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009; 27: 633\u2013641.","journal-title":"J Hypertens"},{"key":"BFhr2013134_CR14","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH . Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992.National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404\u20132410.","journal-title":"JAMA"},{"key":"BFhr2013134_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.0954-6820.1988.tb19625.x","volume":"224","author":"C Bengtsson","year":"1988","unstructured":"Bengtsson C, Lapidus L, Stendahl C, Waldenstr\u00f6m J . Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988; 224: 549\u2013555.","journal-title":"Acta Med Scand"},{"key":"BFhr2013134_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/archinte.1973.03650090077014","volume":"132","author":"R Klein","year":"1973","unstructured":"Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA . Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973; 132: 401\u2013410.","journal-title":"Arch Intern Med"},{"key":"BFhr2013134_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","volume":"141","author":"DS Freedman","year":"1995","unstructured":"Freedman DS, Williamson DF, Gunter EW, Byers T . Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1995; 141: 637\u2013644.","journal-title":"Am J Epidemiol"},{"key":"BFhr2013134_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","volume":"36","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P . Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072\u20131078.","journal-title":"Hypertension"},{"key":"BFhr2013134_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/01.HYP.34.1.144","volume":"34","author":"MH Alderman","year":"1999","unstructured":"Alderman MH, Cohen H, Madhavan S, Kivlighn S . Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144\u2013150.","journal-title":"Hypertension"},{"key":"BFhr2013134_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1053\/j.ajkd.2011.04.025","volume":"58","author":"L Neri","year":"2011","unstructured":"Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA . Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis 2011; 58: 398\u2013408.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2215\/CJN.09420911","volume":"7","author":"WC Liu","year":"2012","unstructured":"Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC . Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2012; 7: 541\u2013548.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFhr2013134_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/01.HYP.0000161184.10873.ea","volume":"45","author":"F Viazzi","year":"2005","unstructured":"Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R . Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991\u2013996.","journal-title":"Hypertension"},{"key":"BFhr2013134_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1253\/circj.70.885","volume":"70","author":"K Matsumura","year":"2006","unstructured":"Matsumura K, Ohtsubo T, Oniki H, Fujii K, Iida M . Gender-related association of serum uric acid and left ventricular hypertrophy in hypertension. Circ J 2006; 70: 885\u2013888.","journal-title":"Circ J"},{"key":"BFhr2013134_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1253\/circj.CJ-08-0626","volume":"73","author":"H Mitsuhashi","year":"2009","unstructured":"Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K . Uric acid and left ventricular hypertrophy in Japanese men. Circ J 2009; 73: 667\u2013672.","journal-title":"Circ J"},{"key":"BFhr2013134_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/01.HYP.0000200033.14574.14","volume":"47","author":"Y Iwashima","year":"2006","unstructured":"Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y . Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006; 47: 195\u2013202.","journal-title":"Hypertension"},{"key":"BFhr2013134_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1291\/hypres.28.133","volume":"28","author":"A Kurata","year":"2005","unstructured":"Kurata A, Shigematsu Y, Higaki J . Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005; 28: 133\u2013139.","journal-title":"Hypertens Res"},{"key":"BFhr2013134_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF . Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50: 239\u2013247.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1399-0012.2010.01244.x","volume":"25","author":"Y Caliskan","year":"2011","unstructured":"Caliskan Y, Gorgulu N, Yelken B, Akturk F, Yazici H, Turkmen A, Sever MS . Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients. Clin Transplant 2011; 25: 368\u2013374.","journal-title":"Clin Transplant"},{"key":"BFhr2013134_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ajh\/hps020","volume":"26","author":"SC Chen","year":"2013","unstructured":"Chen SC, Chang JM, Yeh SM, Su HM, Chen HC . Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease. Am J Hypertens 2013; 26: 243\u2013249.","journal-title":"Am J Hypertens"},{"key":"BFhr2013134_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A . Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982\u2013992.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2013134_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613\u2013618.","journal-title":"Circulation"},{"key":"BFhr2013134_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0952-8180(92)90111-D","volume":"4","author":"Y Wang","year":"1992","unstructured":"Wang Y, Moss J, Thisted R . Predictors of body surface area. J Clin Anesth 1992; 4: 4\u201310.","journal-title":"J Clin Anesth"},{"key":"BFhr2013134_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0735-1097(86)80476-4","volume":"7","author":"IW Hammond","year":"1986","unstructured":"Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH . The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639\u2013650.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2013134_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/jhh.2011.104","volume":"26","author":"C Cuspidi","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A, Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens 2012; 26: 343\u2013349.","journal-title":"J Hum Hypertens"},{"key":"BFhr2013134_CR35","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","volume":"266","author":"GN Rao","year":"1991","unstructured":"Rao GN, Corson MA, Berk BC . Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266: 8604\u20138608.","journal-title":"J Biol Chem"},{"key":"BFhr2013134_CR36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ . Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739\u20131742.","journal-title":"Kidney Int"},{"key":"BFhr2013134_CR37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","volume":"89","author":"MG Netea","year":"1997","unstructured":"Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW . The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 1997; 89: 577\u2013582.","journal-title":"Blood"},{"key":"BFhr2013134_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","volume":"40","author":"S Watanabe","year":"2002","unstructured":"Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ . Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355\u2013360.","journal-title":"Hypertension"},{"key":"BFhr2013134_CR39","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.95.5.1247","volume":"95","author":"T Yokoyama","year":"1997","unstructured":"Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL . Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247\u20131252.","journal-title":"Circulation"},{"key":"BFhr2013134_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.RES.83.4.345","volume":"83","author":"PH Sugden","year":"1998","unstructured":"Sugden PH, Clerk A . \"Stress-responsive\" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 1998; 83: 345\u2013352.","journal-title":"Circ Res"},{"key":"BFhr2013134_CR41","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1681\/ASN.2005121336","volume":"17","author":"E Agabiti-Rosei","year":"2006","unstructured":"Agabiti-Rosei E, Muiesan ML, Salvetti M . Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J Am Soc Nephrol 2006; 17: S104\u2013S108.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2013134_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1253\/circj.71.716","volume":"71","author":"T Nakahara","year":"2007","unstructured":"Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G, Sumi T, Ogawa T, Yamashina A . Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide. Circ J 2007; 71: 716\u2013721.","journal-title":"Circ J"},{"key":"BFhr2013134_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00392-007-0636-3","volume":"97","author":"O Yiginer","year":"2008","unstructured":"Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS . Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol 2008; 97: 334\u2013340.","journal-title":"Clin Res Cardiol"},{"key":"BFhr2013134_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0895-4356(89)90061-9","volume":"42","author":"W Levine","year":"1989","unstructured":"Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J . Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989; 42: 257\u2013267.","journal-title":"J Clin Epidemiol"},{"key":"BFhr2013134_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0026-0495(98)90056-7","volume":"47","author":"CS Wingrove","year":"1998","unstructured":"Wingrove CS, Walton C, Stevenson JC . The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 1998; 47: 435\u2013438.","journal-title":"Metabolism"},{"key":"BFhr2013134_CR46","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.amjcard.2009.07.018","volume":"104","author":"BR Cowan","year":"2009","unstructured":"Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL, ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol 2009; 104: 1484\u20131489.","journal-title":"Am J Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2013134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2013134","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2013134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:12:23Z","timestamp":1684429943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2013134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFhr2013134"],"URL":"https:\/\/doi.org\/10.1038\/hr.2013.134","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,3]]}}}